It should be noted that earlier studies have shown that Swedish mutant APP transgenic mice had significantly increased brain levels of Aβ at a steady state [29], suggesting that BACE1 plays an essential role in the amyloidogenic pathway in AD pathogenesis and is a good therapeutic target for AD treatment. The gene discussed is BACE1; the disease is Alzheimer disease.